Global Solid Tumor Testing Market Growth, Size & Forecast 2023-2028

The Global Solid Tumor Testing Market size is projected to grow at a CAGR of around 8.0% during the forecast period, 2023-28.                                                       

Global Solid Tumor Testing Market Dynamics:

Mounting Incidence of Cancer to Augment the Market Growth – The rising number of cancer patients in the world is the leading cause of the Global Solid Tumor Testing Market growth. The increasing geriatric population coupled with a sedentary lifestyle & other hereditary risk factors, are the major factors for the spike of cancer cases worldwide. For instance, the recent incidence trends projected by the American Cancer Society for FY2021 indicate a slight boost of nearly 2.50% compared to the earlier projections being postulated for FY2020.

The reported incidence rates pertaining to various types of cancers, such as breast & lung, are constantly supplementing during the past few years. The demand for respective testing assay kits is significantly growing, owing to the upscaling prominence of early diagnosis to avoid further risks considering the rates being on a spike. Thus, in line with this, it is predicted that the Global Solid Tumor Testing Market would witness an upsurging demand in the coming years.

Download a free sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/solid-tumor-testing-market.html

Market Dimensions & Projections

·        Pricing Evaluation

·        Recent Strategic Moves by Companies

·        Primary Stakeholders

·        Import/Export Trend Analysis

·        Competitive Landscape Assessment

·        Emerging Opportunities

·        Market Trends and Indicators

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report. 

Browse Full Report including (TOC+ List of Table and Figures): https://www.marknteladvisors.com/research-library/solid-tumor-testing-market.html

Global Solid Tumor Testing Market Segmentation:

The market report categorizes the market based on different segments and geographical analysis.

Study Timeline:

-Base Year: 2022

-Historical Period: 2018 to 2021

-Forecast Period: 2023-28

• By Cancer Type
  • Prostate Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Endometrial Cancer
  • Melanoma
  • Lung Cancer
  • Thyroid Cancer
  • Brain Cancer
  • Ovarian Cancer
  • Liver Cancer
  • Other Cancer Types
• By Application
  • Clinical
    • Diagnostics
    • Treatment and Monitoring
    • Screening
    • Prognostics
  • Research
    • Biomarker Discovery
    • Personalized Medicine
• By End Users
  • Hospitals, Diagnostic Laboratories, and Reference Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic Research Institutions
  • Other End Users
• By Technologies
  • In Situ Hybridization
  • Immunohistochemistry
  • Polymerase Chain Reaction
  • Next-Generation Sequencing
  • Other Technologies (Microarray, ELISA, and LC/MS)
• By Region
  • North America
  • South America
  • Europe
  • Middle East & Africa
  • Asia Pacific

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including -   Abbott Laboratories, ARUP Laboratories, ASURAGEN, INC., Bio-Rad Laboratories, Inc, Beijing Genomics Institute (BGI) Genomics Co., Ltd, F. Hoffmann-La Roche Ltd, Guardant Health, Illumina, Inc., Invivoscribe, Inc., Invitae Corporation, Laboratory Corporation of America Holdings, NeoGenomics Laboratories, Inc., Opko Health, OmniSeq, QIAGEN N.V, Quest Diagnostics Inc, Others

Have questions? Our consultant is ready to assist: https://www.marknteladvisors.com/query/request-customization/solid-tumor-testing-market.html

We follow a tried-and-tested research methodology that blends top-down and bottom-up approaches to deliver highly accurate market insights. Every report is powered by data triangulation, ensuring well-rounded and validated findings.

From smart sample selection and reliable data collection to in-depth analysis and precise forecasting, our process is designed to minimize error and maximize impact.

About Us –

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Us

MarkNtel Advisors

Email: sales@marknteladvisors.com

Website: www.marknteladvisors.com

Latest Press Release - https://www.marknteladvisors.com/press-release